Skip to content

PACOO: what changed

BE 0459.505.826NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€214,990
2024 · €150,481+€64,510
Equity
€580,485
2024 · €418,648+€161,837
Cash
€287,675
2024 · €299,978-€12,303
Balance sheet total
€1.3m
2024 · €1.2m+€76,551

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€83,591

    up €83,591 (+66.9%), from €124,997 to €208,588

  • Tangible fixed assets -€53,251

    down €53,251 (-18.3%), from €290,747 to €237,496

    of which Land and buildings: -€52,575

  • Current investments +€39,993

    up €39,993 (+9.8%), from €408,649 to €448,642

  • Receivables within one year +€17,768

    up €17,768 (+21.0%), from €84,438 to €102,206

    of which Other amounts receivable: +€16,899

Equity and liabilities
  • Reserves +€161,837

    up €161,837 (+45.4%), from €356,648 to €518,485

    of which Distributable reserves: +€161,837

  • Debts after one year -€150,109

    down €150,109 (-28.4%), from €528,066 to €377,957

  • Other debts +€49,698

    first reported in 2025, at €49,698

  • Trade debts +€17,646

    up €17,646 (+28.9%), from €61,009 to €78,655

Income statement
  • Financial income +€44,404

    up €44,404 (+1,303%), from €3,408 to €47,813

  • Taxes +€29,114

    up €29,114 (+39.6%), from €73,523 to €102,637

  • Staff costs -€22,484

    down €22,484 (-18.6%), from €120,725 to €98,241

  • Gross operating margin +€22,379

    up €22,379 (+5.3%), from €421,567 to €443,945

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €150,481
Gross operating margin +€22,379
Staff costs +€22,484
Depreciation +€95
Other operating charges +€211
Financial income +€44,404
Financial charges +€4,051
Taxes -€29,114
Result 2025 €214,990
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€228,180
Investment -€39,993
Financing -€200,489
Cash 2024 €299,978
Net result for the year +€214,990
Depreciation +€53,251
Stocks and contracts -€83,591
Receivables within one year -€17,768
Deferred charges and accrued income -€752
Trade debts +€17,646
Tax, wage and social debts -€5,533
Other debts +€49,698
Accrued charges and deferred income +€239
Current investments -€39,993
Debts after one year -€150,109
Current portion of long-term debt +€2,773
Contributions, distributions and other -€53,153
Cash 2025 €287,675
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,209,274 €1,285,824 +€76,551 +6.3%
Fixed assets 21/28 €290,747 €237,496 -€53,251 -18.3%
Tangible fixed assets 22/27 €290,747 €237,496 -€53,251 -18.3%
Land and buildings 22 €289,684 €237,109 -€52,575 -18.1%
Furniture and vehicles 24 €1,063 €387 -€676 -63.6%
Current assets 29/58 €918,527 €1,048,328 +€129,801 +14.1%
Stocks and contracts in progress 3 €124,997 €208,588 +€83,591 +66.9%
Stocks 30/36 €124,997 €208,588 +€83,591 +66.9%
Amounts receivable within one year 40/41 €84,438 €102,206 +€17,768 +21.0%
Trade receivables 40 €72,573 €73,442 +€869 +1.2%
Other amounts receivable 41 €11,865 €28,764 +€16,899 +142%
Current investments 50/53 €408,649 €448,642 +€39,993 +9.8%
Cash at bank and in hand 54/58 €299,978 €287,675 -€12,303 -4.1%
Deferred charges and accrued income 490/1 €465 €1,217 +€752 +162%
Total equity and liabilities 10/49 €1,209,274 €1,285,824 +€76,551 +6.3%
Equity 10/15 €418,648 €580,485 +€161,837 +38.7%
Contributions 10/11 €62,000 €62,000 = 0.0%
Contributions outside capital 11 €62,000 €62,000 = 0.0%
Other 1109/19 €62,000 €62,000 = 0.0%
Reserves 13 €356,648 €518,485 +€161,837 +45.4%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Reserves not available under the articles 1311 €6,200 €6,200 = 0.0%
Tax-exempt reserves 132 €36,704 €36,704 = 0.0%
Distributable reserves 133 €313,743 €475,580 +€161,837 +51.6%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €790,626 €705,340 -€85,286 -10.8%
Amounts payable after more than one year 17 €528,066 €377,957 -€150,109 -28.4%
Financial debts 170/4 €528,066 €377,957 -€150,109 -28.4%
Amounts payable within one year 42/48 €262,393 €326,977 +€64,584 +24.6%
Current portion of amounts payable after more than one year 42 €147,336 €150,109 +€2,773 +1.9%
Trade debts 44 €61,009 €78,655 +€17,646 +28.9%
Suppliers 440/4 €61,009 €78,655 +€17,646 +28.9%
Taxes, remuneration and social security 45 €54,048 €48,515 -€5,533 -10.2%
Taxes 450/3 €34,723 €29,896 -€4,827 -13.9%
Remuneration and social security 454/9 €19,325 €18,619 -€706 -3.7%
Other amounts payable 47/48 - €49,698 +€49,698
Accrued charges and deferred income 492/3 €167 €406 +€239 +143%
Remuneration, social security and pensions 62 €120,725 €98,241 -€22,484 -18.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €53,346 €53,251 -€95 -0.2%
Other operating charges 640/8 €5,407 €5,196 -€211 -3.9%
Gross operating margin 9900 €421,567 €443,945 +€22,379 +5.3%
Operating profit (loss) 9901 €242,089 €287,258 +€45,169 +18.7%
Financial income 75/76B €3,408 €47,813 +€44,404 +1,303%
Recurring financial income 75 €3,408 €47,813 +€44,404 +1,303%
Financial charges 65/66B €21,494 €17,443 -€4,051 -18.8%
Recurring financial charges 65 €21,494 €17,443 -€4,051 -18.8%
Profit (loss) for the period before taxes 9903 €224,004 €317,627 +€93,624 +41.8%
Income taxes 67/77 €73,523 €102,637 +€29,114 +39.6%
Profit (loss) for the period 9904 €150,481 €214,990 +€64,510 +42.9%
Profit (loss) for the period to be appropriated 9905 €150,481 €214,990 +€64,510 +42.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€856,410 to €1.1m

Midpoint €950,771 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €580,485
Capitalised earnings €1.1m to €1.6m
Indication €856,410 to €1.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€580,485
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€580,485

Capitalised earnings

net result for the year (9904)
2025
€214,990
2024
€150,481
2023
€110,110
2022
€53,153
2021
€49,300
Average result
€158,527
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.1m / €1.3m / €1.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.